Press Releases COGNOA PRESS RELEASES Cognoa Launches Pivotal Study of the First Digital Diagnostic for Autism. Read More » October 24, 2019 Cognoa and EVERSANA™ announce partnership to advance the commercialization standard for prescription digital medicines. Read More » September 10, 2019 Cognoa Licenses Innovative Digital Therapeutic Technology. Read More » April 10, 2019 Cognoa Receives FDA Breakthrough Designations for Autism Diagnostic and Digital Therapeutic Devices. Read More » February 6, 2019 Cognoa Selected by Cambia Health Solutions to Provide Support for Employees Raising Young Children. Read More » January 8, 2019 Cognoa Demonstrates Advances of its AI-Based Technology for Identifying Autism in Children Read More » August 27, 2018 « Previous Page1 Page2 Page3 Page4 Page5 Page6 Next » For media inquiries, please contact [email protected] Learn about our efforts to advance pediatric behavioral healthcare. Learn More
Cognoa Launches Pivotal Study of the First Digital Diagnostic for Autism. Read More » October 24, 2019
Cognoa and EVERSANA™ announce partnership to advance the commercialization standard for prescription digital medicines. Read More » September 10, 2019
Cognoa Receives FDA Breakthrough Designations for Autism Diagnostic and Digital Therapeutic Devices. Read More » February 6, 2019
Cognoa Selected by Cambia Health Solutions to Provide Support for Employees Raising Young Children. Read More » January 8, 2019
Cognoa Demonstrates Advances of its AI-Based Technology for Identifying Autism in Children Read More » August 27, 2018
